SPONSORS

20/20 Pharmacy in Calgary, AB is a top-rated pharmaceutical facility dedicated to providing exceptional healthcare services to the community. As one of the leading pharmacies in the area, 20/20 Pharmacy prides itself on delivering personalized care and expert advice to every patient who walks through its doors.

At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face.

​

We Advance Courageous Science

Our goal is to transform treatment for a broad range of debilitating diseases by controlling a part of the immune system known as the complement cascade.

With nearly a dozen clinical and pre-clinical programs underway, we believe we have only begun to unlock the potential of targeting C3 across many serious diseases.

​

Learn more at apellis.com

Biogen is a leading biotechnology company with more than 40 years of biologics experience across multiple therapeutic categories. With our proven track record of developing, manufacturing and supplying biologics for Canada and other global markets, our vision is to unlock the potential of biosimilars across multiple therapeutic areas to allow millions more people access to transformative biologics. Our anti-TNF biosimilars are currently serving >250,000 patients for a variety of conditions in the EU and in Canada we have now launched the first ophthalmology biosimilar . Our biosimilar solutions have the potential to help more patients with retinal vascular disorders preserve and restore their vision.

​

Learn more at biogenlinc.ca/biosimilars

At AbbVie, we set our sights on a future where vision lasts a lifetime. With a legacy of 75 years in eye care, we’re proud to offer 125 eye care products that help to preserve and protect vision for patients around the world. We treat conditions from the front to the back of the eye, including glaucoma, ocular surface disease, and retinal diseases.

​

Learn more at abbvie.com/our-science/therapeutic-focus-areas/eye-care.html

Bayer is committed to delivering “Science for a better life” by advancing a portfolio of innovative treatments. Our pharmaceuticals portfolio covers six key therapeutic areas: pulmonology, oncology, hematology, cardiology, women’s health and ophthalmology.

In conditions such as wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and retinal vein occlusion (RVO), the retina, and in particular the macula (the portion of the retina responsible for fine vision), is damaged by fluid from new blood vessels leaking into the tissue, causing swelling (edema). Bayer’s development activities in the field of neovascular retinal diseases concentrate on counteracting the formation of these new, pathological blood vessels and leakage by inhibiting the growth factors involved in the formation of new blood vessels.

Learn more at bayer.com/en/ca/canada-pharmaceuticals

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible.

Learn more at RocheCanada.com

​Alcon helps people see brilliantly. As the global leader in surgical retina, Alcon represents not only quality and continuous improvement, but also an indispensable partner providing breakthrough technologies that can help you improve your patient outcomes and your practice. Our Surgical and Vision Care products touch the lives of many Canadians and people worldwide and our more than 200 Canadian associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care.

​

Learn more at alcon.ca

Bausch + Lomb offers a complete portfolio of surgical products for cataract, retinal, refractive and corneal surgery. Our range of products includes state-of-the-art technology with the Stellaris ELITE™ Vision Enhancement System, the TECHNOLAS® TENEO™ 317 Model 2 Excimer Laser, the VICTUS® Femtosecond Laser Platform, a full range of intraocular lenses including enVista® and enVista® Toric, and EyeCee® One Preloaded as well as a range of quality instruments through the Bausch + Lomb Storz® Ophthalmic Instruments and Synergetics portfolios.

​

Learn more at bausch.com